Cite
HARVARD Citation
McDonald, C. et al. (2017). Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 390 (10101), pp. 1489-1498. [Online].